Skip to search.
 FTSE 100 Up 0.14%

More On GLAXF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-Other OTC
21.00 0.00(0.00%) 14:30
Prev Close:21.00
Open:21.00
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:1.13884
Next Earnings Date:N/A
Day's Range:21.00 - 21.00
52wk Range:18.45 - 23.35
Volume:132
Avg Vol (3m):20,361
Market Cap:101.64b
P/E (ttm):8.34
EPS (ttm):2.52
Div & Yield:1.11 (5.21%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.23
P/S (ttm):2.91
Ex-Dividend Date:12-May-16

Analysts

Annual EPS Est (Dec-16) :88.55
Quarterly EPS Est (Jun-16) :20.55
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):1.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback